FranΓ§aisπ See the interactive version (live chart) β
For Lumentum, we replayed every analyst price target of the past 12 months and measured the real outcome: 46% were profitable, average return +71% (176 calls). At 3 months: +25% average return (54% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Raymond James | 32 | 44% | +56% |
| Barclays | 21 | 19% | +10% |
| Needham | 19 | 53% | +106% |
| Rosenblatt | 19 | 37% | +86% |
| Susquehanna | 17 | 59% | +118% |
The analyst consensus on Lumentum (LITE) is "Buy" (42 bullish, 0 bearish calls over 12 months). This is not advice: historically, 46% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $1,040 (+9% vs $956), ranging from $820 to $1,300 (11 analysts).
Over 1 year, 46% of analyst targets on Lumentum were profitable, for an average return of +71% (across 176 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $1,040 within 12 months, i.e. +9% vs the current price. The most bullish targets $1,300, the most cautious $820.
Note: analyst targets are 12-month (median $1,040, +9%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (46%), and the stock's past trajectory.
Detailed valuation data for Lumentum is available in the interactive analysis.
π See the full interactive analysis of Lumentum β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.